Walvax Biotechnology Co., Ltd. (SHE:300142)
China · Delayed Price · Currency is CNY 14.75
+0.67 (4.76%)
Oct 9, 2026, 3:04 PM CST
Walvax Biotechnology Market Cap
Walvax Biotechnology has a market cap or net worth of 23.59 billion as of October 9, 2026. It is the 4,698th most valuable company in the world and the 736th biggest in China. Its market cap has increased by 27.05% in one year.
Market Cap
23.59B
Enterprise Value
24.05B
Revenue
2.10B
Global Rank
Country Rank
#736 China
PE Ratio
125.69
ChartMarket Cap Chart
Since November 12, 2010, Walvax Biotechnology's market cap has increased from 13.63B to 23.59B, an increase of 73.01%. That is a compound annual growth rate of 3.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 23.59B | 35.20% |
| Dec 31, 2025 | 17.45B | -9.69% |
| Dec 31, 2024 | 19.32B | -48.62% |
| Dec 29, 2023 | 37.60B | -41.50% |
| Dec 30, 2022 | 64.27B | -28.12% |
| Dec 31, 2021 | 89.42B | 50.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shijiazhuang Yiling Pharmaceutical | 25.71B |
| Zhejiang Huahai Pharmaceutical | 24.81B |
| Hubei Jumpcan Pharmaceutical | 23.98B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 23.69B |
| Livzon Pharmaceutical Group | 22.98B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 22.19B |
| Hybio Pharmaceutical | 20.98B |
| Tasly Pharmaceutical Group | 20.93B |